http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007308403-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91f344ed3a42ef612ee6ec3c5778291d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-04
filingDate 2006-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daae38776a9e2614327cfd74c9147171
publicationDate 2007-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2007308403-A
titleOfInvention Topical skin preparation
abstract PROBLEM TO BE SOLVED: To provide a skin external preparation based on a new action mechanism. The external preparation for skin of the present invention comprises a drug having a muscle relaxing action as an active ingredient, and dantrolene sodium is preferably used as the active ingredient having a muscle relaxing action. According to the external preparation for skin of the present invention, the muscular defense is suppressed and the circulatory insufficiency of the local tissue is improved by the agent having a muscle relaxing action, so that the prevention and treatment of inflammation of the skin and subcutaneous tissue is intended Can do. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105992586-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015087097-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757360-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015087097-A3
priorityDate 2006-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11209271-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01128923-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05201879-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06157248-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003530345-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002519310-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005511725-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003055133-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450695195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451474829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9862125
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6914273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6537202

Total number of triples: 45.